Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001415889-24-015366

Director acquired 4,660 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Molineaux Christopher P. Director 2024-06-01 Option exercise +4,660 53,163 D
Derivatives
Molineaux Christopher P. Director 2024-06-01 Option exercise · Restricted Stock Units −4,660 0 D
Loading xslF345X05/form4-06042024_040614.xml…